Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.5 USD | +3.12% | -2.61% | +130.62% |
Business Summary
Number of employees: 85
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 21-10-17 |
Jeffrey Jones
CTO | Chief Tech/Sci/R&D Officer | 53 | 22-02-27 |
Jacquelyn Sumer
CMP | Compliance Officer | 46 | 22-08-14 |
Chief Tech/Sci/R&D Officer | 57 | 17-12-31 | |
Kevin Johnston
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-30 |
Chad Messer
IRC | Investor Relations Contact | - | 22-02-28 |
Corinne Savill
PRN | Corporate Officer/Principal | 64 | 17-01-31 |
Stephen Andre
HRO | Human Resources Officer | 62 | 22-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 17-07-31 | |
Thomas Ebeling
BRD | Director/Board Member | 65 | 17-07-31 |
Stephen Webster
BRD | Director/Board Member | 63 | 20-08-31 |
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 21-10-17 |
Director/Board Member | 52 | 22-02-27 | |
David Ryan
BRD | Director/Board Member | 57 | 22-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 57,634,234 | 55,035,466 ( 95.49 %) | 0 | 95.49 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+130.62% | 1.35B | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- CGEM Stock
- Company Cullinan Therapeutics, Inc.